Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study

L Bpm Stevens Brentjens; D Obukhova; B Delvoux; J E den Hartog; B N Bui; F Mol; J P de Bruin; D Besselink; G Teklenburg; F Morgan; M Baker; F Jm Broekmans; R J T van Golde; M Zamani Esteki; A Romano

doi:10.1530/RAF-23-0065

Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study

L Bpm Stevens Brentjens, D Obukhova, B Delvoux, J E den Hartog, B N Bui, F Mol, J P de Bruin, D Besselink, G Teklenburg, F Morgan, M Baker, F Jm Broekmans, R J T van Golde, M Zamani Esteki, A Romano^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17B-estradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/ICSI. Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n=15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n=15). Formation of 17B-estradiol (oxidative 17B hydroxysteroid dehydrogenases [HSDs]), estrone (reductive HSD17Bs) and inhibition of HSD17B1 activity was determined by high-performance liquid chromatography (HPLC). The endometrial transcriptome was profiled using RNA-sequencing followed by principal component analysis and differentially expressed gene (DEG) analysis. The False Discovery Rate-adjusted p<0.05 and log FoldChange>0.5 were selected as screening threshold. Formation and inactivation of 17B-estradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n=12) were considered (27.1%,n=5 versus 16.2%,n=7,p=0.04). Gene-expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolizing enzymes in the endometrium. In the primary infertile subgroup (n=10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid metabolizing enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups.

Original language	English
Article number	e230065
Number of pages	14
Journal	Reproduction and Fertility
Volume	4
Issue number	4
DOIs	https://doi.org/10.1530/RAF-23-0065
Publication status	Published - 1 Dec 2023

Access to Document

10.1530/RAF-23-0065Licence: CC BY-NC-ND

Cite this

Stevens Brentjens, L. B., Obukhova, D., Delvoux, B., den Hartog, J. E., Bui, B. N., Mol, F., de Bruin, J. P., Besselink, D., Teklenburg, G., Morgan, F., Baker, M., Broekmans, F. J., van Golde, R. J. T., Esteki, M. Z., & Romano, A. (2023). Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study. Reproduction and Fertility, 4(4), Article e230065. https://doi.org/10.1530/RAF-23-0065

@article{6c7dcf90587345a0a5b5d85afac13a97,

title = "Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study",

abstract = "Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17B-estradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/ICSI. Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n=15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n=15). Formation of 17B-estradiol (oxidative 17B hydroxysteroid dehydrogenases [HSDs]), estrone (reductive HSD17Bs) and inhibition of HSD17B1 activity was determined by high-performance liquid chromatography (HPLC). The endometrial transcriptome was profiled using RNA-sequencing followed by principal component analysis and differentially expressed gene (DEG) analysis. The False Discovery Rate-adjusted p<0.05 and log FoldChange>0.5 were selected as screening threshold. Formation and inactivation of 17B-estradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n=12) were considered (27.1%,n=5 versus 16.2%,n=7,p=0.04). Gene-expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolizing enzymes in the endometrium. In the primary infertile subgroup (n=10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid metabolizing enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups.",

author = "{Stevens Brentjens}, {L Bpm} and D Obukhova and B Delvoux and {den Hartog}, {J E} and Bui, {B N} and F Mol and {de Bruin}, {J P} and D Besselink and G Teklenburg and F Morgan and M Baker and Broekmans, {F Jm} and {van Golde}, {R J T} and Esteki, {M Zamani} and A Romano",

year = "2023",

month = dec,

day = "1",

doi = "10.1530/RAF-23-0065",

language = "English",

volume = "4",

journal = "Reproduction and Fertility",

issn = "2633-8386",

publisher = "BioScientifica Ltd.",

number = "4",

}

Stevens Brentjens, LB, Obukhova, D, Delvoux, B, den Hartog, JE, Bui, BN, Mol, F, de Bruin, JP, Besselink, D, Teklenburg, G, Morgan, F , Baker, M, Broekmans, FJ, van Golde, RJT , Esteki, MZ & Romano, A 2023, 'Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study', Reproduction and Fertility, vol. 4, no. 4, e230065. https://doi.org/10.1530/RAF-23-0065

TY - JOUR

T1 - Local production of 17 β-oestradiol in the endometrium during the implantation window

T2 - a pilot study

AU - Stevens Brentjens, L Bpm

AU - Obukhova, D

AU - Delvoux, B

AU - den Hartog, J E

AU - Bui, B N

AU - Mol, F

AU - de Bruin, J P

AU - Besselink, D

AU - Teklenburg, G

AU - Morgan, F

AU - Baker, M

AU - Broekmans, F Jm

AU - van Golde, R J T

AU - Esteki, M Zamani

AU - Romano, A

PY - 2023/12/1

Y1 - 2023/12/1

N2 - Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17B-estradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/ICSI. Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n=15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n=15). Formation of 17B-estradiol (oxidative 17B hydroxysteroid dehydrogenases [HSDs]), estrone (reductive HSD17Bs) and inhibition of HSD17B1 activity was determined by high-performance liquid chromatography (HPLC). The endometrial transcriptome was profiled using RNA-sequencing followed by principal component analysis and differentially expressed gene (DEG) analysis. The False Discovery Rate-adjusted p<0.05 and log FoldChange>0.5 were selected as screening threshold. Formation and inactivation of 17B-estradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n=12) were considered (27.1%,n=5 versus 16.2%,n=7,p=0.04). Gene-expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolizing enzymes in the endometrium. In the primary infertile subgroup (n=10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid metabolizing enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups.

AB - Sex steroids are converted to bioactive metabolites and vice versa by endometrial steroid-metabolising enzymes. Studies indicate that alterations in this metabolism might affect endometrial receptivity. This pilot study determined whether the endometrial formation and inactivation of 17B-estradiol differed between the supposedly embryo-receptive endometrium and non-receptive endometrium of women undergoing IVF/ICSI. Endometrial biopsies were obtained from IVF/ICSI patients 5-8 days after ovulation in a natural cycle, prior to their second IVF/ICSI cycle with fresh embryo transfer (ET). Endometrial biopsies from patients who achieved clinical pregnancy after fresh ET (n=15) were compared with endometrial biopsies from patients that did not conceive after fresh ET (n=15). Formation of 17B-estradiol (oxidative 17B hydroxysteroid dehydrogenases [HSDs]), estrone (reductive HSD17Bs) and inhibition of HSD17B1 activity was determined by high-performance liquid chromatography (HPLC). The endometrial transcriptome was profiled using RNA-sequencing followed by principal component analysis and differentially expressed gene (DEG) analysis. The False Discovery Rate-adjusted p<0.05 and log FoldChange>0.5 were selected as screening threshold. Formation and inactivation of 17B-estradiol resulted similar between groups. Inhibition of HSD17B1 activity was significantly higher in the non-pregnant group when only primary infertile women (n=12) were considered (27.1%,n=5 versus 16.2%,n=7,p=0.04). Gene-expression analysis confirmed the presence of HSD17B1 (encoding HSD17B1), HSD17B2 (encoding HSD17B2) and 33 of 46 analysed steroid metabolizing enzymes in the endometrium. In the primary infertile subgroup (n=10) 12 DEGs were found including LINC02349 which has been linked to implantation. However, the exact relationship between steroid metabolizing enzyme activity, expression and implantation outcome requires further investigation in larger, well-defined patient groups.

U2 - 10.1530/RAF-23-0065

DO - 10.1530/RAF-23-0065

M3 - Article

SN - 2633-8386

VL - 4

JO - Reproduction and Fertility

JF - Reproduction and Fertility

IS - 4

M1 - e230065

ER -

Local production of 17 β-oestradiol in the endometrium during the implantation window: a pilot study

Abstract

Access to Document

Fingerprint

Cite this